Stay updated on Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2024-08-28T02:12:47.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements in the latest release.
    Difference
    0.8%
    Check dated 2024-08-13T22:57:32.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    No Change Detected
  6. Check
    33 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2024-07-29T20:52:26.000Z thumbnail image
  7. Check
    37 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-07-26T17:19:44.000Z thumbnail image
  8. Check
    39 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-07-24T16:09:41.000Z thumbnail image
  9. Check
    40 days ago
    Change Detected
    Summary
    The study has been updated to version v2.10.0, replacing the previous version v2.9.7.
    Difference
    0.5%
    Check dated 2024-07-23T14:45:41.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial page.